Interestingly, this is in line with results in murine models that highlights the importance of IL-18 in negatively regulating NAFLD/NASH development through inflammasome activation mediated by gut microbiota (34). The gene discussed is IL18; the disease is metabolic dysfunction-associated steatohepatitis.